Oramed Pharmaceuticals Inc.

(ORMP) Trade

By |

Profile

Oramed Pharmaceuticals Inc is a pharmaceutical company which is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The ORMD-0801 is a proprietary product which is an orally ingestible insulin capsule for the treatment of diabetes. Its other product includes Oral Glucagon-like peptide-1 which is an incretin hormone, a type of gastrointestinal hormone that stimulates the secretion of insulin from the pancreas.

Contact Information

Website: www.oramed.com
Email: info@oramed.com
Main Phone: +1 844 967-2633
Address: 142 West 57th Street
Address 2: Givat-Ram, P.O. Box 39098
State: NY
City / Town: New York
Country: USA
Postal Code: 10019

Issuer Information

Exchange: NSC
CEO: Nadav Kidron
Employees: 13
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 3.89 $ -0.03 (-0.77%)
Last Price 3.89 Change $ -0.03 Change % -0.77 Tick N/A
Bid 3.89 Bid Size 300.00 Ask 3.92 Ask Size 200.00
Open 3.84 High 4.06 Low 3.81 Prev Close 3.92
Last Trade Volume 23,123 52 Wk Hi 9.48 52 Wk Low 3.90
Market Cap 67.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 17,378,359.00 EPS (TTM) -0.86 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 8
Number of Buys 0 7
Number of Sells 0 1
Net Activity 0 227771
Last 10 Buys Shares
Xiaopeng Li 1,000
Xiaopeng Li 1,000
Kidron Nadav 1,000
Kidron Nadav 1,000
Kidron Nadav 1,000
Kidron Nadav 1,000
Kidron Nadav 1,000
Kidron Nadav 1,000
Kidron Nadav 1,000
Kidron Nadav 1,000
Last 10 Sell Shares
Miriam Kidron 1,000
Miriam Kidron 1,000
Harold Jacob 1,000
Miriam Kidron 1,000
Miriam Kidron 1,000
Miriam Kidron 1,000
Michael Berelowitz 1,000
Michael Berelowitz 1,000
Michael Berelowitz 1,000
Miriam Kidron 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 25 25 25 25
Low Target Price Estimate 20 20 20 20
Mean Target Price Estimate 23.33 23.33 23.33 23.33
Standard Deviation 2.89 2.89 2.89 2.89
Date of Most Recent Estimate 04/17/18 04/17/18 04/17/18 06/11/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1